Settlement agreement between Bausch & Lomb and Alcon Labs establishes a cross-licensing relationship that allows Alcon to continue selling its ICAP AREDS ocular vitamins worldwide and gives B&L global rights under one or more Alcon patents. B&L filed an infringement suit against the ICAPS manufacturer shortly after receiving a patent for its Ocuvite PreserVision line of antioxidant and mineral eye vitamins in December 2003. The formula was developed by B&L and the National Eye Institute for use in NEI's Age-Related Eye Disease Study (AREDS) and remains the only vitamin demonstrated effective in preserving eye health and vision (1"The Tan Sheet" Oct. 15, 2001, p. 3)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.